Resveratrol attenuates ischemia-reperfusion-induced leukocyte-endothelial cell adhesive interactions and prolongs allograft survival across the MHC barrier

Circulation Journal

Volumn 71, Issue 3, 2007, Pages 423-428

  Hsieh, Yu Hsuan ^a   Huang, Shiang Suo ^b   Wei, Fu Chan ^c   Hung, Li Man ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Antioxidant; Composite tissue allotransplantation; Ischemia reperfusion; Rejection; Resveratrol

Indexed keywords

ANTIOXIDANT; RESVERATROL;

ALLOTRANSPLANTATION; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL INTERACTION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; ISCHEMIA; LEUKOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; RAT; TISSUE TRANSPLANTATION;

ANIMALS; CELL ADHESION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GRAFT SURVIVAL; HISTOCOMPATIBILITY; LEUKOCYTE ROLLING; LEUKOCYTES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SKIN TRANSPLANTATION; STILBENES; TRANSPLANTATION, HOMOLOGOUS; VENULES;

EID: 33947171433     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.423     Document Type: Article

References (38)

1. Chen L, Han Y, Yang F, Zhang T. High-speed counter-current chromatography separation and purification of resveratrol and piceid from polygonum cuspidatum. J Chromatogr 2001; 907: 343-346.
2. Langcake P, Pryce RJ. A new class of phytoalexins from grape-vines. Experientia 1997; 33: 151-152.
3. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-1526.
4. Wu SL, Yu L, Meng KW, Ma ZH, Pan CE. Resveratrol prolongs allograft survival after liver transplantation in rats. World J Gastroenterol 2005; 11: 4745-4749.
5. Wu SL, Yu L, Pan CE, Jiao XY, Lv Y, Fu J, et al. Apoptosis of lymphocytes in allograft in a rat liver transplantation model induced by resveratrol. Pharmacol Res 2006; 54: 19-23.
6. Arichi H, Kimura Y, Okuda H, Bana K, Kozawa M, Arichi S. Effects of stilbene components of the roots of polygonum on lipid metabolism. Chem Pharm Bull 1982; 30: 1766-1770.
7. Kimura Y, Okuda H, Arichi S. Effects of stilbene derivatives on arachidonate metabolosm in leukocytes. Biochim Biophys Acta 1985; 837: 209-212.
8. Ragazzi E, Froldi G, Fassina G. Resveratrol activity on guinea pig isolated trachea from normal and albumin-sensitized animals. Pharmacol Res Commun 1988; 20: 79-82.
9. Bertelli AA, Giovannini L, Giannessi D, Migliori M, Bernini W, Fregoni M, et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React 1995; 17: 1-3.
10. Jayatilake GS, Jayasuriya H, Lee ES, Koonchanok NM, Geahlen RL, Ashendel CL, et al. Kinase inhibitors polygonum cuspidatum. J Nat Prod 1993; 56: 1805-1810.
11. Rotondo S, Rajtar G, Manarinis S, Celardo A, Rotillio D, de Gaetano G, et al. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol 1998; 123: 1691-1699.
12. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993; 341: 1103-1104.
13. Hung LM, Chen JK, Huang SS, Lee RS, Su MJ. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res 2000; 47: 549-555.
14. Hung LM, Su MJ, Chen JK. Resveratrol protect myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms. Free Radic Biol Med 2004; 36: 774-781.
15. Lee WPA, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 1991; 87: 401-411.
16. Hoffman LA, Codner MA, Shuster BA, Bogossian N, Egozi L, Harper AD, et al. Donor leukocyte migration following extremity transplantation in an experimental model. Plast Reconstr Surg 1992; 90: 999-1006.
17. Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998; 338: 1813-1821.
18. Olszewski WL. Innate immunity processes in organ allografting: Their contribution to acute and chronic rejection. Ann Transplant 2005; 10: 5-9.
19. Land WG. The role of postischemic reperfusion injury and other nonantigen dependent inflammatory pathways in transplantation. Transplantation 2005; 79: 505-514.
20. Behrend M. Immune-adhesion molecules in the prevention of allograft rejection and reperfusion injury. Expert Opin Invest Drugs 2000; 9: 789-805.
21. Le Moine O, Louis H, Stordeur P, Collet JM, Goldman M, Devière J. Role of reactive oxygen intermediates in interleukin 10 release after cold liver ischemia and reperfusion in mice. Gastroenterology 1997; 113: 1701-1706.
22. Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991; 260: G355-G362.
23. Loong CC, Chang YH, Wu TH, King KL, Yang WC, Wu CW, et al. Antioxidant supplementation may improve renal transplant function: A preliminary report. Transplant Proc 2004; 36: 2438-2439.
24. Freitas I, Bertone V, Guarnaschelli C, Ferrigno A, Boncompagni E, Rizzo V, et al. In situ demonstration of improvement of liver mitochondria function by melatonin after cold ischemia. In Vivo 2006; 20: 229-237.
25. Amersi F, Nelson SK, Shen XD, Kato H, Melinek J, Kupiec-Weglinski JW, et al. Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury. Proc Natl Acad Sci USA 2002; 99: 8915.
26. Huang SS, Wei FC, Hung LM. Ischemic preconditioning attenuates postischemic leukocyte-endothelial cell interactions. Circ J 2006; 70: 1070-1075.
27. Wei W, Wei FC, Hung LM. Diazoxide ameliorates microcirculatory disturbances through PKC-dependent pathway in IR-injured rat cremaster muscles. J Biomed Sci 2005; 12: 521-529.
28. Hayasaki T, Kaikita K, Okuma T, Yamamoto E, Kuziel WA, Ogawa H, et al. CC chemokine receptor-2 deficiency attenuates oxidative stress and infarct size caused by myocardial ischemia-reperfusion in mice. Circ J 2006; 70: 342-351.
29. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003; 284: G15-G26.
30. Kinugasa Y, Ogino K, Furuse Y, Shiomi T, Tsutsui H, Yamamoto T, et al. Allopurinol improves cardiac dysfunction after ischemia-reperfusion via reduction of oxidative stress in isolated perfused rat hearts. Circ J 2003; 67: 781-787.
31. Domanski L, Dolegowska B, Safranow K, Rozanski J, Myslak M, Romanowski M, et al. Activity of CuZn-superoxide dismutase, catalase and glutathione peroxidase in erythrocytes in kidney allografts during reperfusion in patients with and without delayed graft function. Clin Transplant 2006; 20: 67-71.
32. Lehmann TG, Luedde T, Schwabe RF, Bunzendahl H, Samulski RJ, Lemasters JJ, et al. Minimizing oxidative stress by gene delivery of superoxide dismutase accelerates regeneration after transplantation of reduced-size livers in the rat. Liver Transplant 2006; 12: 550-559.
33. Halliwell B, Gutteridge JM. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990; 280: 1-8.
34. Birlouez-Aragon I, Tessier FJ. Antioxidant vitamins and degenerative pathologies: A review of vitamin C. J Nutr Health Aging 2003; 7: 103-109.
35. Traber MG. Determinants of plasma vitamin E concentrations. Free Radic Biol Med 1994; 16: 229-239.
36. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996; 20: 933-956.
37. Shahidi F, Wanasundara PK. Phenolic antioxidants. Crit Rev Food Sci Nutr 1992; 32: 67-103.
38. Huang SS, Tsai MC, Chih CL, Hung LM, Tsai SK. Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia. Life Sci 2001; 69: 1057-1065.